William R. Larue - Jun 10, 2021 Form 4 Insider Report for Tracon Pharmaceuticals, Inc. (TCON)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TCON	Director Stock Option (Right to Buy)	Award	$0	+10.5K		$0.00	10.5K	Jun 10, 2021	Common Stock	10.5K	$6.55	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders.